|
PXL/HO/Cir-103/2023-24 Date: 13.03.2024
Hyderabad
Dear Sir/Madam,
Subject:CapacityBuildingProgramon“Importance of Quality Compliance & Patient Safety– Industry Practices & RegulatoryExpectations” by Pharmexcil & FDA-Goaon 27th March2024(Wednesday) at Vivanta Goa, Panaji.
Members are aware that Pharmexcil have launched the Capacity Building Program on“Importance of Quality Compliance and patient safety –Industry Practices & Regulatory Expectations” with the first in the series on September 15th Ahmedabad and subsequently at Indore, Bangalore, Chennai, Mumbai, Hyderabad and Chandigarh in order to createawarenessand tofocusonthethreepillarsSafety,efficacyand Quality culture to uplift their understanding of Regulatory, GMP, Quality & Safety norms.
We are now organisisng the capacity building program on “Importance of Quality Compliance and patient safety –Industry Practices & Regulatory Expectations” in association with FDA on 27th March (Wednesday) at Vivanta- Goa, Panaji. The program would be covering the topics of Schedule-M, Quality Culture & Best Practices, USFDA Audit Preparedness, Impurity Profiling (Nitrosamines & DEG/EG contaminations) & Advancements through Technology etc
Goa Chapter of Capacity Building Program on
“Importance of Quality Compliance & Patient Safety”
(Industry Practices & Regulatory Expectations)
|
Date & Time:
|
27th March 2024(Wednesday) scheduled from 9:30AM -4:30pm
|
|
Venue :
|
Vivanta-Goa, Panaji , St. Anne's Junction, Off, Dayanand Bandodkar Marg, Panaji, Goa 403001
|
|
Registration Link :
|
https://docs.google.com/forms/d/e/1FAIpQLSeE4UoSbChWixJ4Av9o7Ajeha9mFM8DDifY5XLogFvzL6Ippw/viewform?usp=sf_link
|
|
Agenda :
|
Tentative Agenda Enclosed
|
|
Fee Details
|
Rs.500/- per participant
|
|
Bank Details
|
Name of the Account - PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA (PHARMEXCIL)
Type of Account – CURRENT
Account No- 510131000001693
IFSC Code: UBIN0805220
Bank Name & Address- UNION BANK OF INDIA, S.R.NAGAR BRANCH, HYDERABAD
GST No- 36AADCP4643C1ZO (Telangana)
|
|
Target Audience
|
Pharma Manufacturers including Production, quality control & Quality Assurance & Regulatory department
API & Excipients manufacturers
Raw material suppliers
Testing Laboratories
|
Member companies are requested to register your participation through the Google form before 23.03.2024 and actively participate in this full day Program and make it a grand success. We are confident that the topics presented by distinguished speakers during the technical sessions will be of significant value to all participants.
With regards,
Udaya Bhaskar
Director General
|
